Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
The American Review of Respiratory Disease
|
August 1, 1973
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs
M Dworski
Transactions of the American Clinical and Climatological Association
|
March 17, 2011
Vaccination Against Tuberculosis. Comparative Results Obtained with Koch's Bacillen Emulsion, Calmette's B.C.G., and the Caseous Vaccine of the Saranac Laboratory
H M Kinghorn, M Dworski
Transactions of the American Clinical and Climatological Association
|
March 17, 2011
A Vaccine for Tuberculosis: Second Communication
H M Kinghorn, M Dworski
The American Review of Respiratory Disease
|
August 1, 1973
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man
H M Vandiviere, M Dworski, I G Melvin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
The American Review of Respiratory Disease
|
August 1, 1973
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs
M Dworski
Transactions of the American Clinical and Climatological Association
|
March 17, 2011
Vaccination Against Tuberculosis. Comparative Results Obtained with Koch's Bacillen Emulsion, Calmette's B.C.G., and the Caseous Vaccine of the Saranac Laboratory
H M Kinghorn, M Dworski
Transactions of the American Clinical and Climatological Association
|
March 17, 2011
A Vaccine for Tuberculosis: Second Communication
H M Kinghorn, M Dworski
The American Review of Respiratory Disease
|
August 1, 1973
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man
H M Vandiviere, M Dworski, I G Melvin, et al.
Page
of 1